JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Motonobu Nishimura
Masanori Ogiwara
Masaaki Kato
Shunei Kyo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimura, M.
Right arrow Articles by Kyo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimura, M.
Right arrow Articles by Kyo, S.
Related Collections
Right arrow Mechanical Circulatory Assistance

J Thorac Cardiovasc Surg 2003;126:1190-1192
© 2003 The American Association for Thoracic Surgery

Brief communication

Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device

Motonobu Nishimura, MDa,*, Masanori Ogiwara, MDa, Masayuki Ishikawa, MDa, Syogo Yatsu, MDa, Ayumu Masuoka, MDa, Nobuyuki Okamura, MDa, Kazuhito Imanaka, MDa, Masaaki Kato, MDa, Haruhiko Asano, MDa, Shunei Kyo, MDa

a Department of Cardiovascular Surgery, Saitama Medical School, Iruma-gun, Saitama, Japan

Received for publication February 13, 2003; accepted for publication March 24, 2003.

* Address for reprints: Motonobu Nishimura, MD, Department of Cardiovascular Surgery, Saitama Medical School, 38 Moro-hongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan
nishimur@saitama-med.ac.jp

The first 20% of the full text of this article appears below.

Patients with end-stage heart failure who receive support from a left ventricular assist system (LVAS) have been shown to tolerate malignant ventricular arrhythmia fairly well.1,2 The duration of malignant arrhythmia in the previous reports was at most a little more than 10 days. This report describes a patient who has been in sustained ventricular fibrillation (VF) for more than 1 year and has been supported by an LVAS without showing any symptoms.

Clinical summary

A 24-year-old woman, who demonstrated dilated cardiomyopathy, was first referred to us for heart failure and ventricular arrhythmia 5 years ago. At that time, she received the maximum medication and did well. She remained well until the age of 23 years, when she returned with profound heart failure and ventricular tachyarrhythmia resistant to medical therapy. Catecholamine was administered, and workup for cardiac transplantation was started. She experienced VF and was resuscitated using the percutaneous extracorporeal membrane oxygenator system (Emersave, Terumo, Tokyo, Japan). She was immediately brought to the . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.